Philippe Rogueda
13 SlideShares 17 Followers 1 Folgen
Personal Information
Unternehmen/Arbeitsplatz
Hong Kong, Hong Kong Hong Kong
Beruf
Executive Director at Aedestra Ltd
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.aedestra.com
Info
Vision, Excellence and Determination Pharma Executive with a track record of driving business growth within the drug delivery technology sector. Key strengths include: driving product development from initial concept through to clinical studies and registration on oral inhaled and nasal technologies; providing regulatory affairs and quality advice and to optimise strategies for brand and generic products within various legislative frameworks; deep knowledge of developing markets particularly China and the Far East; Consulting, R&D audit, R&D portfolio, financial due diligence and strategic planning.
Kontaktdetails
Tags
inhaler aerosol medical devices dpi copd inhalation asthma merxin drug delivery lung can propellant hfa propane plastic www.merxin.com container vial pet isobutane mrx002 pmdi ecigarettes vapping formulation dry powder inhaler mrx003 mrx001 respirosense amiko dtx digital therapeutics cannatech nasal thc cannabinoids cbd benefit risk smoking glycerol propylene glycol respiratory e-liquid e-cigs rogueda kwok aedestra nictoine electronic cigarette e-cigarettes pressure pharmaceutical india china asia aspergillosis voriconazole pulmonary
Mehr anzeigen

Präsentationen

(12)
Alle anzeigen

In Form An Introduction Ph Rogueda 18 May 2010

Vor 13 Jahren • 339 Aufrufe

HFA pMDI Patents Perspectives Gold Mine Or Minefield Ph Rogueda 12 December 2009

Vor 13 Jahren • 434 Aufrufe

Open Innovation In The Inhalation Field Academia And Industry As Partners Ph Rogueda December 2008

Vor 13 Jahren • 494 Aufrufe

Is There A Future For Triple Therapy In Copd Ph Rogueda 14 April 2011

Vor 13 Jahren • 427 Aufrufe

Choosing the right device: The case for nebulisers

Vor 12 Jahren • 2132 Aufrufe

Has innovation in inhalation drug delivery run out of steam?

Vor 9 Jahren • 1546 Aufrufe

ADA APS talk 4 APS 4 April 15

Vor 9 Jahren • 1254 Aufrufe

Reformulating voriconazole for inhaled therapy

Vor 8 Jahren • 858 Aufrufe

The future of generic dry powder inhalers

Vor 7 Jahren • 2048 Aufrufe

e-Cigarettes: lessons for Inhalation technologists

Vor 7 Jahren • 1060 Aufrufe

Vaping Liquids: A Formulator’s Dream?

Vor 6 Jahren • 843 Aufrufe

Inhaler Devices For Cannabinoids Controlled Delivery Cannatech 2018

Vor 6 Jahren • 709 Aufrufe

Dokumente

(1)

16 12 06 DDL 27 poster e-cigarettes Kwok Rogueda Aedestra

Vor 7 Jahren • 676 Aufrufe

Gefällt mir

(1)

16 12 06 DDL 27 poster e-cigarettes Kwok Rogueda Aedestra

Philippe Rogueda • Vor 7 Jahren
Personal Information
Unternehmen/Arbeitsplatz
Hong Kong, Hong Kong Hong Kong
Beruf
Executive Director at Aedestra Ltd
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.aedestra.com
Info
Vision, Excellence and Determination Pharma Executive with a track record of driving business growth within the drug delivery technology sector. Key strengths include: driving product development from initial concept through to clinical studies and registration on oral inhaled and nasal technologies; providing regulatory affairs and quality advice and to optimise strategies for brand and generic products within various legislative frameworks; deep knowledge of developing markets particularly China and the Far East; Consulting, R&D audit, R&D portfolio, financial due diligence and strategic planning.
Tags
inhaler aerosol medical devices dpi copd inhalation asthma merxin drug delivery lung can propellant hfa propane plastic www.merxin.com container vial pet isobutane mrx002 pmdi ecigarettes vapping formulation dry powder inhaler mrx003 mrx001 respirosense amiko dtx digital therapeutics cannatech nasal thc cannabinoids cbd benefit risk smoking glycerol propylene glycol respiratory e-liquid e-cigs rogueda kwok aedestra nictoine electronic cigarette e-cigarettes pressure pharmaceutical india china asia aspergillosis voriconazole pulmonary
Mehr anzeigen